sorafenib has been researched along with Esophagitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, KH; Chou, YH; Hsieh, CH; Lu, YF; Weng, MT | 1 |
| Bonomi, L; Imarisio, I; Paglino, C; Porta, C | 1 |
1 review(s) available for sorafenib and Esophagitis
| Article | Year |
|---|---|
Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.
Topics: Acneiform Eruptions; Antineoplastic Agents; Benzenesulfonates; Erythema; Esophagitis; Exanthema; Humans; Hypertension; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib | 2007 |
1 other study(ies) available for sorafenib and Esophagitis
| Article | Year |
|---|---|
Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Candidiasis; Carcinoma, Hepatocellular; Dose Fractionation, Radiation; Esophagitis; Fluconazole; Heartburn; Hiccup; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Proton Pump Inhibitors; Sorafenib; Stomach Ulcer | 2016 |